Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1499.4000 -10.30 (-0.68%)
NSE Sep 26, 2025 15:31 PM
Volume: 2.7M
High volume today

logo
Cipla Ltd.
edited 03 Nov 2021
1499.40
-0.68%
Cipla unit gets notice from US firm for termination of acquisition deal
Cipla unit gets notice from US firm for termination of acquisition deal
Moneycontrol
In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around Rs 1,560 crore).
Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
Cipla unit gets notice from US firm for termination of acquisition deal
Business Standard | 03 Nov 2021
More from Cipla Ltd.
Recommended
The new H1B fee: Who will it hurt the most?
The Baseline | 26 Sep 2025, 05:06PM
Five Interesting Stocks Today - September 26, 2025
The Baseline | 26 Sep 2025, 04:56PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
| 20 May 2022